Papillary renal cell carcinoma with clear cell cytomorphology and chromosomal loss of 3p

被引:32
作者
Füzesi, L
Gunawan, B
Bergmann, F
Tack, S
Braun, S
Jakse, G
机构
[1] Aachen Tech Univ, Sch Med, Inst Pathol, Aachen, Germany
[2] Aachen Tech Univ, Sch Med, Dept Urol, Aachen, Germany
关键词
chromosome; clear cell; cytogenetics; kidney; papillary; renal cell carcinoma;
D O I
10.1046/j.1365-2559.1999.00709.x
中图分类号
Q2 [细胞生物学];
学科分类号
071009 [细胞生物学]; 090102 [作物遗传育种];
摘要
Aims: Cytogenetic studies on renal cell carcinomas (RCCs) have disclosed a correlation between chromosome aberrations and histomorphological features. Nevertheless, it is still controversial whether the cytomorphology of the tumour cells (clear cell, chromophilic, chromophobe) or their growth pattern (non-papillary, papillary) is more discriminative for the combined histomorphological-cytogenetic classification of RCCs. Methods and results: Three RCCs with papillary growth pattern and clear cell cytomorphology were analysed by classical cytogenetics using standard G-banding techniques. Each tumour displayed clonal aberrations leading to loss of terminal 3p chromosomal segments. Monosomy :14 was also consistently found. Trisomy 17 was not observed in any of the tumours. Conclusions: This series of three RCCs consisting of clear cells with papillary architecture revealed chromosomal aberrations characteristic for the conventional (clear cell) RCC. Irrespective of the predominant papillary growth pattern, none of the cases were characterized by trisomy of chromosomes 3q, 7, 8, 12, 16, 17 and 20 and loss of Y chromosome which are widely regarded as the most consistent genetic alterations for papillary RCC. Therefore, our cytogenetic findings provide evidence that papillary clear cell RCCs should be classified according to their cytomorphology rather than their growth pattern even when papillary architecture is prominent.
引用
收藏
页码:157 / 161
页数:5
相关论文
共 24 条
[1]
TUMOR-SUPPRESSOR GENE ALLELIC LOSS IN HUMAN RENAL CANCERS [J].
BROOKS, JD ;
BOVA, GS ;
MARSHALL, FF ;
ISAACS, WB .
JOURNAL OF UROLOGY, 1993, 150 (04) :1278-1283
[2]
DALCIN P, 1989, AM J CLIN PATHOL, V92, P408
[3]
THE DISTRIBUTION OF CYTOKERATIN ANTIGENS IN THE KIDNEY AND IN RENAL TUMORS [J].
FLEMING, S ;
SYMES, CE .
HISTOPATHOLOGY, 1987, 11 (02) :157-170
[4]
[5]
PROGNOSTIC-SIGNIFICANCE OF MORPHOLOGIC PARAMETERS IN RENAL-CELL CARCINOMA [J].
FUHRMAN, SA ;
LASKY, LC ;
LIMAS, C .
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 1982, 6 (07) :655-663
[6]
GNARRA JR, 1993, UROL CLIN N AM, V20, P207
[7]
ISCN, 1995, INT SYST HUM CYT NOM
[8]
Kovacs G, 1997, J PATHOL, V183, P131, DOI 10.1002/(SICI)1096-9896(199710)183:2<131::AID-PATH931>3.0.CO
[9]
2-G
[10]
KOVACS G, 1989, AM J PATHOL, V134, P27